Appili Therapeutics Receives FDA and Health Canada Clearance to Begin Clinical Trials on ATI-1501
Appili Therapeutics Receives FDA and Health Canada Clearance to Begin [...]
Newsletter Sign Up
Recent Posts
- Medicenna Announces Closing of Public Offering of $6,900,000
- Poul Sorensen Receives the 2019 Bloom Burton Award
- BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States
- Q2 2019 Share Price Performance
- ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million